A detailed history of Paladin Wealth, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Paladin Wealth, LLC holds 7,126 shares of ABT stock, worth $926,593. This represents 0.69% of its overall portfolio holdings.

Number of Shares
7,126
Previous 7,184 0.81%
Holding current value
$926,593
Previous $977 Million 2.32%
% of portfolio
0.69%
Previous 0.76%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 14, 2025

SELL
$120.51 - $136.62 $6,989 - $7,923
-58 Reduced 0.81%
7,126 $954 Million
Q2 2025

Jul 08, 2025

BUY
$123.95 - $138.08 $19,832 - $22,092
160 Added 2.28%
7,184 $977 Million
Q1 2025

Apr 09, 2025

BUY
$111.1 - $140.22 $13,887 - $17,527
125 Added 1.81%
7,024 $932 Million
Q4 2024

Jan 29, 2025

BUY
$111.93 - $119.39 $37,944 - $40,473
339 Added 5.17%
6,899 $780 Million
Q3 2024

Oct 11, 2024

BUY
$100.07 - $118.13 $656,459 - $774,932
6,560 New
6,560 $748 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Paladin Wealth, LLC Portfolio

Follow Paladin Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paladin Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paladin Wealth, LLC with notifications on news.